Guggenheim Capital’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,883
Closed -$38K 2112
2022
Q1
$38K Buy
+10,883
New +$38.4K ﹤0.01% 2109
2018
Q2
Sell
-71,464
Closed -$227K 2535
2018
Q1
$227K Sell
71,464
-534,145
-88% -$2.15M ﹤0.01% 2592
2017
Q4
$2.97M Buy
605,609
+538,349
+800% +$3.12M 0.01% 1368
2017
Q3
$461K Sell
67,260
-541,457
-89% -$3.41M ﹤0.01% 2412
2017
Q2
$4.01M Buy
608,717
+94,944
+18% +$666K 0.01% 1145
2017
Q1
$4.11M Buy
513,773
+127,236
+33% +$1.07M 0.01% 1145
2016
Q4
$3.6M Sell
386,537
-130,340
-25% -$1.35M 0.01% 1219
2016
Q3
$5.47M Sell
516,877
-40,018
-7% -$398K 0.02% 968
2016
Q2
$5.2M Buy
556,895
+57,573
+12% +$585K 0.02% 972
2016
Q1
$5.19M Sell
499,322
-371,861
-43% -$3.4M 0.02% 972
2015
Q4
$8.76M Sell
871,183
-325,948
-27% -$3.27M 0.03% 793
2015
Q3
$10.1M Buy
1,197,131
+126,745
+12% +$1.68M 0.03% 747
2015
Q2
$17.2M Buy
1,070,386
+4,000
+0.4% +$62.2K 0.04% 646
2015
Q1
$15.1M Buy
1,066,386
+164,684
+18% +$2.14M 0.04% 706
2014
Q4
$9.01M Buy
901,702
+76,599
+9% +$656K 0.02% 873
2014
Q3
$7.02M Buy
825,103
+13,734
+2% +$121K 0.02% 1044
2014
Q2
$7.17M Buy
811,369
+1,306
+0.2% +$11.4K 0.02% 1011
2014
Q1
$7.55M Buy
810,063
+128,200
+19% +$1.12M 0.02% 943
2013
Q4
$5.75M Sell
681,863
-18,562
-3% -$188K 0.02% 1025
2013
Q3
$6.17M Sell
700,425
-92,422
-12% -$741K 0.02% 1002
2013
Q2
$5.63M Buy
+792,847
New +$5.48M 0.02% 1002

Other funds holding OPK

Guggenheim Capital's OPK Position: Q2 2022 in Review

Guggenheim Capital sold out of Opko Health (OPK) in Q2 2022, closing a stake of 10,883 shares — an estimated $38K sold.

Guggenheim Capital first reported a position in OPK in Q2 2013 and held it in 21 quarters. The position peaked at $17.2M in Q2 2015. 231 funds tracked by Wall St. Rank hold OPK as of Q2 2022.

  • Guggenheim Capital reported no remaining Opko Health position as of Q2 2022 after selling out during the quarter.
  • Guggenheim Capital sold 10,883 Opko Health shares in Q2 2022, an estimated $38K.
  • Guggenheim Capital first reported a position in Opko Health in Q2 2013 and held it in 21 quarters.
  • Guggenheim Capital's Opko Health position peaked at $17.2M in Q2 2015.
  • 231 funds tracked by Wall St. Rank held Opko Health as of Q2 2022.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.